Syria's health ministry. It runs most public hospitals, registers and prices medicines, and asked the IAEA, WHO and IARC to review the country's cancer services in 2022.
The Ministry of Health runs most of Syria's public hospitals: of 113 public hospitals reporting to WHO's Health Resources and Services Availability Monitoring System (HeRAMS) in 2020, 100 belonged to the Ministry of Health and 13 to the Ministry of Higher Education, which runs the university hospitals. By the end of December 2020, 48% of the 113 were fully functioning, 28% partly and 24% not at all, and cancer treatment services were available in 29% of the functional public hospitals. A 2025 scoping review of the health system describes the Ministry as the body that approved new medicines, monitored their quality and set price controls, with weak enforcement outside the public sector. The coordinates are an approximate Damascus city point.
WHO's Cancer Country Profile 2020 records a national cancer control plan as under development in 2019, cancer management guidelines, early detection guidelines for two cancers and staff in the Ministry dedicated to cancer. The Ministry requested an imPACT Review of national cancer control capacity, carried out in late 2022 by the IAEA, IARC and WHO; the IAEA wrote in June 2023 that the Syrian National Cancer Control Committee, headed by Arwa Azmeh, had agreed to finalise a National Strategy for Cancer Control and an action plan.
WHO's appeal of 24 December 2024 refers to the recent transfer of authority. On 4 June 2025 the IAEA's Director General met President Ahmed Al-Sharaa in Damascus and, during the same visit, signed a memorandum of understanding on cancer control and food security with the Foreign Minister. The Ministry's website, in its archived copy of October 2026, names Dr Musab Al-Ali as Minister of Health and links a form for reporting medicine side effects hosted on the WHO Uppsala Monitoring Centre's VigiFlow system.
Explains why a Syrian with cancer has often paid for medicines out of pocket even where hospital care is free.
This is the most complete map of what is known about cancer care in Syria during the conflict, and it shows how little is measured: the authors report no national cancer registry from 2011 onwards.
Most Syrians with lung cancer were diagnosed too late for curative treatment, and access to care, not only the disease, shaped who survived.
Access to a host country's health system was not enough to give Syrian refugees with cancer good outcomes; the authors call for refugee cancer care to be planned within national cancer programmes.
Puts a price on refugee cancer care for host countries and agencies such as UNHCR, and argues for new financing tied to clear care pathways.
Shows that for a refugee from Syria, whether cancer treatment is paid for can depend on a committee's case-by-case decision.
An early first-hand account of how far cancer care fell during the conflict in every kind of area of Syria, not only besieged ones.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, Cancer registries and population surveillance.
Shares Tishreen University Hospital, Al-Bairouni University Hospital.
Shares International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, Childhood cancers (all types), Cervical cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/